Composition for treating and/or preventing Hepatitis B virus infection and the use thereof
AssigneeYisheng Biopharma (Singapore) Pte Ltd
InventorYi Zhang
Life of this patent
Estimating the term…
Abstract
A composition for treating and/or preventing Hepatitis B virus infection and Hepatitis B virus infection mediated diseases and the method thereof are provided. In some embodiments, the composition includes a polyriboinosinic acid-polyribocytidylic acid (PIC), at least one antibiotic or polyamide compound, at least one positive ion, and Hepatitis B virus surface antigen. In some embodiments, the composition includes PIC, at least one antibiotic or polyamide compound, at least one positive ion, Hepatitis B virus surface antigen and Hepatitis B virus core antigen. The present disclosure also relates to a method of treating and/or preventing Hepatitis B virus infection, particularly for treating chronic HBV infection.
Claims21
A composition comprising:
- polyriboinosinic acid-polyribocytidylic acid (PIC), at least one antibiotic or polyamide compound, at least one positive ion, and HBsAg,
- wherein the concentration of the HBsAg in the composition ranges from 20 μg/unit dose to 60 μg/unit dose.
A method for treating and/or prevention Hepatitis B virus infection, comprising administering a composition to a subject, wherein said composition comprises PIC, at least one antibiotic or polyamide compound, at least one positive ion, and HBsAg,
- wherein the concentration of the HBsAg in the composition ranges from 20 μg/unit dose to 60 μg/unit dose.
Dependencies are inferred from the claim text.